Plenful, Inc.
About Plenful, Inc.
Company overview
Plenful is a San Francisco-based AI-powered workflow automation platform designed for the healthcare industry, especially pharmacies, health systems, and provider groups. Plenful enables healthcare teams to streamline messy, manual, and disparate administrative workflows, automating over 95% of the work involved in billing, authorizations, document processing, and more, typically onboarding in weeks rather than months. Plenful's platform has been deployed across thousands of pharmacies and healthcare operations, including large health systems, specialty and infusion pharmacies, pediatric and provider groups, helping reduce administrative waste, ensure compliance, and unlock revenue opportunities. Product & Service Line Breakdown: 1. 340B Audit & Missed Savings Automation - AI audits 100% of eligible transaction volume. - Identifies full scope of missed savings and referral opportunities in the 340B program for covered entities and pharmacies. 2. Prior Authorization & Intake Authorization Management - End-to-end automation of pharmacy prior authorization workflows, including form generation, submission tracking, and decision follow-up. - Improves throughput by up to 4× while minimizing manual administration. 3. Intelligent Document Processing - Converts unstructured content (PDFs, referral forms, intake documents) into structured data using ML. - Eliminates manual data entry across disparate file formats. 4. Pharmacy Revenue Cycle & Reporting - Complete claims auditing, Part D risk-adjustment workflows, revenue integrity rules, and crosswalk logic. - Enables deep insight into payment processes, optimization opportunities, and billing compliance. 5. Data Integration & Workflow Ingestion - Flexible ingestion from EHRs, HL7/FHIR feeds, APIs, SFTP, PDFs, CSVs, HL7 standards. - Customizable mapping, rules, and crosswalks built to configuration, can onboard new workflows within weeks. 6. AI & Machine Learning Engine - Context-aware ML models trained on healthcare operations data. - Smart decisioning, anomaly detection, revenue opportunity flagging, and intelligent automation rules tailored to healthcare workloads. 7. Scalable Use Case Deployment - Supports deployment across health systems, specialty pharmacy providers, and provider groups. - Automates processes at scale through reusable templates and customizable operational logic for different organizational types.
Keywords
Revenue
EBITDA
Valuation
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenues | $380 MM | $250 MM | $90 MM | $120 MM | $65 MM |
| Gross Profit | $190 MM | $125 MM | $45 MM | $60 MM | $32.50 MM |
| Net Income (Loss) | $43 MM | $25 MM | $9 MM | $12 MM | $6.50 MM |
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $850 MM | $720 MM | $680 MM | $650 MM | $600 MM |
| Total Liabilities | $450 MM | $400 MM | $380 MM | $350 MM | $320 MM |
| Total Equity | $400 MM | $320 MM | $300 MM | $300 MM | $280 MM |
Ratios
Employee Figures
Key Executives
See All401K
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Series B — 2023-05-01
- Expansion financing for product launch.
© 2026 PrivCo Holding Inc. All rights reserved.
No AI Training or Automated Data Extraction.
Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.